Independent
Tenure on this board
10.4 yrs
10 nominees · 5 ballot items.
The Leap Therapeutics special meeting includes five stockholder proposals: Authorized Share Increase, Reverse Stock Split, Leap 2025 Equity Incentive Plan, Private Placement Issuance (change of control), and Adjournment; board recommends voting FOR all.
Amend the Charter to increase authorized common stock from 250,000,000 to 500,000,000 shares and to designate 490,000,000 as Common Stock, with clarifying language regarding DGCL Section 242.
Amend the Charter to permit the Board to effect a reverse stock split in a ratio to be determined within 1:5 to 1:20 within one year of the Special Meeting to regain Nasdaq listing compliance.
Adopt the Leap Therapeutics, Inc. 2025 Equity Incentive Plan to provide for new awards and include an evergreen feature, subject to stockholder approval.
Allow issuance of Common Stock upon exercise of Pre-Funded Warrants and Common Warrants from the Financing Transaction, potentially exceeding 19.99% on a non-discretionary basis under Nasdaq's Change of Control Rule; necessary to complete financing.
Authorize the board to adjourn the Special Meeting to continue soliciting proxies if necessary.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2.2% | 2,342,174 | $2M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7% | 1,818,414 | $1M |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 0.7% | 725,120 | $576K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.4% | 463,490 | $368K |
| 5 | VANGUARD FIDUCIARY TRUST CO | 0.3% | 297,086 | $236K |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.2% | 243,334 | $193K |
| 7 | LPL Financial LLC | 0.2% | 162,494 | $129K |
| 8 | STATE STREET CORP | 0.1% | 140,113 | $111K |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.1% | 107,578 | $85K |
| 10 | GROUP ONE TRADING LLC | 0.1% | 107,416 | $85K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.